June 17, 2008 - Angiotech Pharmaceuticals Inc. recently launched marketing of its Quill SRS MONODERM for superficial ...
Medtronic has extended its line of CRT leads with Attain StarFix OTW (over-the-wire) lead (Model 4195), an active fixation left-heart lead for cardiac resynchronization therapy (CRT).
June 17, 2008 - Visage Imaging will present the Visage Thin Client product family featuring advanced tools for Cardiac ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
June 17, 2008 - The FDA has cleared Medtronic Attain StarFix OTW (over-the-wire) lead (Model 4195), an active fixation ...
June 17, 2008 – Findings indicate that when used with PET technology, BMS747158 demonstrates a favorable radiation ...
June 16, 2008 - Mindray Medical International Ltd. received FDA 510(k) clearance for its DC-3 color ultrasound system ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
June 16, 2008 – Siemens introduced IQ•SPECT, a works-in-progress that is the newest Symbia feature that enables a ...
June 16, 2008 - To help ensure that more healthcare facilities throughout the U.S. have access to the positron emission ...
June 16, 2008 - Datascope Corp. said it has exercised its option to acquire the Peripheral Vascular Stent business of ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 16, 2008 – Philips released today its new Philips BrightView XCT, reportedly the first time a flat panel X-ray detector will be used for CT imaging in nuclear medicine, integrating Philips BrightView SPECT in a coplanar design with advanced flat-detector X-ray CT technology to acquire low dose, high resolution CT images and to improve registration confidence.
June 13, 2008 - MEDRAD signed a distribution and co-marketing partnership agreement with PETNET Solutions, a fully owned ...
June 12, 2008 - Sorin Group closed the sale of its peripheral stent business to Datascope Corp., divesting its noncore ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
In addition to the key function mobile computing serves to enter real-time, bedside information into patients’ ...
June 12, 2008 – The registry arm of a clinical study to assess the safety and effectiveness of Cook Medical’s Zilver PTX Drug-Eluting Peripheral Stent (DES) in treating peripheral arterial disease (PAD) has yielded positive interim results, trial investigators reported at the 2008 SVS Vascular Annual Meeting last week.
New technology has helped miniaturized bar-code drug administration and patient monitoring systems, eliminating the need for bulky machines or cart-based devices. The pocket-sized devices have helped increase patient safety and help speed triage and diagnosis. Alternatives to cart-based drug administration
June 16, 2008
